WebJul 12, 2024 · HORSHAM, Pa., July 12, 2024 -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in combination with pomalidomide and dexamethasone (Pd) for the treatment of adult patients with … WebMar 31, 2024 · SUMMARY. PAVO is an ongoing, phase 1b, open-label, multicenter, dose-finding, proof-of-concept study evaluating the safety, pharmacokinetics (PK), and efficacy of DARZALEX FASPRO for subcutaneous (SC) use in patients with relapsed or refractory multiple myeloma (RRMM) who have received ≥2 prior therapy. 1. Chari et al (2024) 1 …
Darzalex Faspro (Janssen Biotech, Inc.): FDA Package Insert
Web1. Darzalex Faspro [package insert]. Horsham, PA; Janssen Biotech, Inc; November 2024. Accessed February 2024. 2. Referenced with permission from the NCCN Drugs & Biologics Compendium (NCCN Compendium®) for daratumumab and hyaluronidase-fihj. National Comprehensive Cancer Network, 2024. The NCCN Compendium® is a derivative work … WebBACKGROUND: Daratumumab is a CD38-directed monoclonal antibody that is approved by the US Food and Drug Administration for the treatment of multiple myeloma and light-chain amyloidosis. Infusion-related reactions (IRRs) have been reported in 28% to 56% of individuals receiving the intravenous (IV) formulation of daratumumab, necessitating slow … psoas muscle mass index
Darzalex: Package Insert - Drugs.com
WebDARZALEX FASPRO to minimize administration-related reactions [see Dosage and Administration (2.5)]. • Type and screen patients prior to starting DARZALEX FASPRO. … WebDec 23, 2024 · Darzalex Faspro (Janssen Biotech, Inc.): FDA Package Insert Darzalex Faspro Janssen Biotech, Inc. 7 November 2024 DARZALEX FASPRO- daratumumab and hyaluronidase (human recombinant) injection Janssen Biotech, Inc. 1 INDICATIONS AND USAGE 1.1 Multiple Myeloma DARZALEX FASPRO is indicated for the treatment of … WebFeb 13, 2024 · Darzalex is a prescription medicine used to treat the symptoms of Bone Marrow Cancer ( Multiple Myeloma ). Darzalex may be used alone or with other medications. Darzalex belongs to a class of drugs called Antineoplastics, Monoclonal Antibody; Antineoplastics, Anti-CD38 Monoclonal Antibodies. psoas muscle is located